These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15964746)

  • 21. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
    Lee JW; Robertson S
    Ann Clin Psychiatry; 1997 Sep; 9(3):165-9. PubMed ID: 9339882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Are catatonia and neuroleptic malignant syndrome related conditions?].
    Vesperini S; Papetti F; Pringuey D
    Encephale; 2010 Apr; 36(2):105-10. PubMed ID: 20434626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome induced by atypical antipsychotics.
    Farver DK
    Expert Opin Drug Saf; 2003 Jan; 2(1):21-35. PubMed ID: 12904122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome].
    Hirjak D; Sartorius A; Kubera KM; Wolf RC
    Nervenarzt; 2019 Jan; 90(1):12-24. PubMed ID: 30128733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
    Belvederi Murri M; Guaglianone A; Bugliani M; Calcagno P; Respino M; Serafini G; Innamorati M; Pompili M; Amore M
    Drugs R D; 2015 Mar; 15(1):45-62. PubMed ID: 25578944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine-induced neuroleptic malignant syndrome.
    DasGupta K; Young A
    J Clin Psychiatry; 1991 Mar; 52(3):105-7. PubMed ID: 2005072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs: a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database.
    Nakamura M; Yasunaga H; Miyata H; Shimada T; Horiguchi H; Matsuda S
    J Clin Psychiatry; 2012 Apr; 73(4):427-30. PubMed ID: 22154901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum iron in catatonia and neuroleptic malignant syndrome.
    Lee JW
    Biol Psychiatry; 1998 Sep; 44(6):499-507. PubMed ID: 9777183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catatonic syndrome following recovery from neuroleptic malignant syndrome.
    Dent J
    J Intellect Disabil Res; 1995 Oct; 39 ( Pt 5)():457-9. PubMed ID: 8555725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis.
    Osman AA; Khurasani MH
    Br J Psychiatry; 1994 Oct; 165(4):548-50. PubMed ID: 7804674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic catatonia and its relationship to psychogenic catatonia.
    Fricchione GL
    Biol Psychiatry; 1985 Mar; 20(3):304-13. PubMed ID: 2858225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?
    Odagaki Y
    Curr Drug Saf; 2009 Jan; 4(1):84-93. PubMed ID: 19149529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E; Santens P
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome and atypical antipsychotic drugs.
    Ananth J; Parameswaran S; Gunatilake S; Burgoyne K; Sidhom T
    J Clin Psychiatry; 2004 Apr; 65(4):464-70. PubMed ID: 15119907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea.
    Choi HD; Kim KK; Koo BH
    Psychiatry Investig; 2011 Jun; 8(2):174-7. PubMed ID: 21852996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
    Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
    Chiou YJ; Lee Y; Lin CC; Huang TL
    Medicine (Baltimore); 2015 Oct; 94(43):e1752. PubMed ID: 26512569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.